Michael Amoroso - Nov 2, 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
President and CEO, Director
Signature
/s/ John Alexander Kelly, Attorney-in-fact for Michael Amoroso
Stock symbol
DTIL
Transactions as of
Nov 2, 2022
Transactions value $
$0
Form type
4
Date filed
11/4/2022, 04:11 PM
Previous filing
Oct 26, 2022
Next filing
Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Award $0 +850K $0.00 850K Nov 2, 2022 Common Stock 850K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.